T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRI
551
DELISTED
Atrion Corp
ATRI
| $140M | 0.02% |
164,352
-28,879
| -15% | -$25.5M |
|
552
Freeport-McMoran
FCX
$96.9B
| $140M | 0.02% |
12,037,806
+1,155,099
| +11% | +$13.4M |
|
553
McCormick & Company Non-Voting
MKC
$14.2B
| $139M | 0.02% |
1,798,384
+21,520
| +1% | +$1.66M |
|
|
ATVI
554
DELISTED
Activision Blizzard
ATVI
| $139M | 0.02% |
2,950,370
-196,203
| -6% | -$9.01M |
|
555
Ecolab
ECL
$78.1B
| $138M | 0.02% |
701,125
-1,228
| -0.2% | -$228K |
|
|
EBSB
556
DELISTED
Meridian Bancorp, Inc.
EBSB
| $138M | 0.02% |
7,690,721
-34,530
| -0.4% | -$590K |
|
557
Vistra
VST
$49.2B
| $137M | 0.02% |
6,066,101
-637,926
| -10% | -$16M |
|
558
Liberty Latin America Class C
LILAK
$1.67B
| $137M | 0.02% |
9,329,267
+371,491
| +4% | +$6.07M |
|
559
Capital One
COF
$136B
| $137M | 0.02% |
1,509,814
-3,856
| -0.3% | -$345K |
|
|
AEPPL
560
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $137M | 0.02% |
2,579,671
-4,550
| -0.2% | -$238K |
|
561
California Water Service
CWT
$3.09B
| $137M | 0.02% |
2,701,368
-320,252
| -11% | -$16.1M |
|
562
Agios Pharmaceuticals
AGIO
$2.04B
| $137M | 0.02% |
2,737,600
-64,212
| -2% | -$3.43M |
|
563
FB Financial Corp
FBK
$3.1B
| $136M | 0.02% |
3,716,111
+36,438
| +1% | +$1.29M |
|
564
Cavco Industries
CVCO
$4.6B
| $135M | 0.02% |
857,854
+33,105
| +4% | +$4.51M |
|
|
SGI
565
Somnigroup International
SGI
$13.5B
| $135M | 0.02% |
7,367,856
+5,564
| +0.1% | +$89.7K |
|
566
PennyMac Financial
PFSI
$4B
| $135M | 0.02% |
6,080,275
+472,076
| +8% | +$10.5M |
|
567
Liberty Global Class C
LBTYK
$3.46B
| $135M | 0.02% |
5,082,140
+7,033
| +0.1% | +$181K |
|
568
Dominion Energy
D
$59.8B
| $134M | 0.02% |
1,732,724
-962,475
| -36% | -$73.3M |
|
569
Blackrock
BLK
$180B
| $134M | 0.02% |
285,394
-12,411
| -4% | -$5.61M |
|
570
Amneal Pharmaceuticals
AMRX
$6.15B
| $134M | 0.02% |
18,666,125
-1,195,293
| -6% | -$12.2M |
|
571
Flowserve
FLS
$10.3B
| $134M | 0.02% |
2,538,889
+256,887
| +11% | +$12.6M |
|
572
Penumbra
PEN
$12.9B
| $134M | 0.02% |
835,670
+25,476
| +3% | +$3.68M |
|
573
Mettler-Toledo International
MTD
$28.8B
| $133M | 0.02% |
158,908
-1,667
| -1% | -$1.26M |
|
574
Healthcare Realty
HR
$6.58B
| $133M | 0.02% |
4,844,773
+4,741,860
| +4,608% | +$134M |
|
575
Exelixis
EXEL
$12.5B
| $131M | 0.02% |
6,143,165
+1,051,976
| +21% | +$22M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.